- Prostanoids in the treatment of pulmonary arterial hypertension2008 | First Faculty of Medicine
- Plasma endothelin and urinary levels of some prostanoids in autosomal dominant polycystic kidney disease (ADPKD)2000 | First Faculty of Medicine
- Plasma endothelin and urinary levels of selected prostanoids in autosomal dominant polycistic kidney disease (ADPKD)Publication without faculty affiliation
- Prostanoids in vasoactive system of the patients with autosomal dominant polycystic kidney disesae2002 | First Faculty of Medicine
- Long-term agonist stimulation of IP prostanoid receptor depletes the cognate G(s)alpha protein in membrane domains but does not change the receptor level2004 | Publication without faculty affiliation
- Long-term agonist stimulation of IP prostanoid receptor depletes the cognate G(s)alpha protein in membrane domains but does not change the receptor level2004 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Pulmonary arterial hypertension2009 | First Faculty of Medicine
- Do you consider the diagnosis of pulmonary arterial hypertension in elderly patients?2009 | First Faculty of Medicine
- Do you consider the diagnosis of pulmonary arterial hypertension in elderly patients?2009 | Publication without faculty affiliation
- Medicamentous treatment of pulmonary hypertension in 20112011 | First Faculty of Medicine
- Drug therapy of pulmonary arterial hypertension in 20142014 | First Faculty of Medicine
- Medical treatment of pulmonary arterial hypertension2005 | First Faculty of Medicine
- Pulmonary arterial hypertension in systemic connective diseases +12008 | Faculty of Medicine in Hradec Králové
- COX-1 is coupled with mPGES-1 and ABCC4 in human cervix cancer cells2009 | Central Library of Charles University
- COX-1 is coupled with mPGES-1 and ABCC4 in human cervix cancer cells +12009 | First Faculty of Medicine
- COX-1 is coupled with mPGES-1 and ABCC4 in human cervix cancer cells2009 | Central Library of Charles University, Faculty of Pharmacy in Hradec Králové
- Contemporary methods in the treatment of chronic pulmonary hypertension2009 | First Faculty of Medicine
- Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)2020 | First Faculty of Medicine
- Raynaud's Phenomenon2023 | First Faculty of Medicine
- Endothelin A receptor blocker atrasentan lowers blood pressure by the reduction of nifedipine-sensitive calcium influx in Ren-2 transgenic rats fed a high-salt diet2015 | Third Faculty of Medicine
- New possibilities in the treatment of chronic thromboembolic pulmonary hypertension2005 | First Faculty of Medicine
- New lipid mediators : their pathophysiology and clinical significance2014 | First Faculty of Medicine
- Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients2014 | First Faculty of Medicine
- Current advances in the treatment of chronic pulmonary hypertension2023 | First Faculty of Medicine